News for 'Drugs Administration'

US regulator not happy with Sun Pharma's reply on import alert

US regulator not happy with Sun Pharma's reply on import alert

Rediff.com21 May 2014

In March, the FDA had issued an import alert, banning formulations and active pharmaceutical ingredients from the factory.

Sun Pharma open to large acquisitions post Ranbaxy

Sun Pharma open to large acquisitions post Ranbaxy

Rediff.com25 Mar 2015

Sun Pharma open to large acquisitions post Ranbaxy.

US sets new record with over 3,000 COVID deaths in 1 day

US sets new record with over 3,000 COVID deaths in 1 day

Rediff.com10 Dec 2020

The previous single-day record was on May 7 at 2,769 deaths.

Trump's personal lawyer Rudy Giuliani tests positive for coronavirus

Trump's personal lawyer Rudy Giuliani tests positive for coronavirus

Rediff.com7 Dec 2020

Giuliani, 76, has been taken to the Medstar Georgetown University Hospital in Washington DC, according to US media reports.

The mistakes Daiichi Sankyo made in the Ranbaxy deal

The mistakes Daiichi Sankyo made in the Ranbaxy deal

Rediff.com12 May 2016

The FDA actions eventually led to a $500-million fine for Ranbaxy as well as the effective mothballing of many of its Indian factories.

'Everybody's going to get infected'

'Everybody's going to get infected'

Rediff.com27 Dec 2021

'In the likelihood that Omicron is circulating, you have a much greater chance of getting infected now, than you did during the Age of Delta.'

COVAX urges equal recognition of WHO approved vaccines

COVAX urges equal recognition of WHO approved vaccines

Rediff.com2 Jul 2021

Calling for 'equal recognition of vaccines', COVAX on Thursday urged all governments to recognise as 'fully vaccinated' those people who have received COVID-19 vaccines deemed safe by World Health Organisation, saying any move that restricts travel of people based on the vaccines they have received is 'counter-effective, both in spirit and outcome'.

'A lot has been done between India and the US in the last two years than it was done before'

'A lot has been done between India and the US in the last two years than it was done before'

Rediff.com23 Jun 2023

'With Trump, the relationship was very transactional, whereas with President Biden it is very structured.'

'Ham-handed' action against Snapdeal to hurt business: Pilot

'Ham-handed' action against Snapdeal to hurt business: Pilot

Rediff.com3 May 2015

He said action was akin to holding highway builders responsible for lane violations

Novavax set for India launch with Serum Institute as partner

Novavax set for India launch with Serum Institute as partner

Rediff.com15 Jun 2021

The Covid-19 vaccine demonstrated an overall 90.4 per cent efficacy in phase 3 clinical trials, reports Sohini Das

No plans to reduce workforce: Ranbaxy

No plans to reduce workforce: Ranbaxy

Rediff.com2 Oct 2013

The company has been reported to be retrenching staff.

Panel to investigate botched sterlisation surgeries

Panel to investigate botched sterlisation surgeries

Rediff.com14 Nov 2014

A single-member commission under retired judge Anita Jha was constituted on Firday to probe the botched sterilisation surgeries at Bilaspur's government-run medical camps, which have so far claimed lives of 13 young women and left nearly 138 ill, and asked to submit its report within three months.

Bengaluru start-up prints 3D tissue that functions like human liver

Bengaluru start-up prints 3D tissue that functions like human liver

Rediff.com23 Dec 2015

In India, thousands of lives are lost every year because of unavailability of organs

Available now: A 'female Viagra', but it comes with a warning

Available now: A 'female Viagra', but it comes with a warning

Rediff.com19 Aug 2015

The first drug to treat low sexual desire in premenopausal women, dubbed "female Viagra", has been approved in the United States, but with a warning about potentially dangerous side effects such as severe low blood pressure and fainting.

Army asks personnel not to consume Maggi

Army asks personnel not to consume Maggi

Rediff.com3 Jun 2015

The Indian Army on Wednesday issued an advisory asking its personnel not to consume Maggi noodles.

New York nurse first to get Covid vaccine in US

New York nurse first to get Covid vaccine in US

Rediff.com14 Dec 2020

The news comes as the United States approaches 300,000 deaths from COVID-19.

Markets end flat on caution ahead of Fed, RBI meet

Markets end flat on caution ahead of Fed, RBI meet

Rediff.com16 Sep 2013

The broader markets ended negatively with mid-caps and small-caps shedding 0.5 per cent on the BSE.

UN chief says will take COVID-19 vaccine publicly, calls it his 'moral obligation'

UN chief says will take COVID-19 vaccine publicly, calls it his 'moral obligation'

Rediff.com10 Dec 2020

Guterres reiterated his call for a COVID-19 vaccine to be a global public good available to everywhere and particularly, available in Africa.

Why US FDA is cracking down on India's shrimp shipments

Why US FDA is cracking down on India's shrimp shipments

Rediff.com12 Feb 2019

US, the largest market for Indian shrimp exporters, is peeved over the use of banned antibiotics.

Noodle bar? Centre steps in as food regulators ask all states to test Maggi

Noodle bar? Centre steps in as food regulators ask all states to test Maggi

Rediff.com3 Jun 2015

The trouble for Nestle's Maggi started in Uttar Pradesh last month and has now spread nationwide. The Food and Drug Administration has directed all states on Wednesday to get sample of India's most popular instant noodles tested for high content of lead and mono-sodium glutamate, a taste enhancer.

Why US' revocation may not have much effect on HCQs exports

Why US' revocation may not have much effect on HCQs exports

Rediff.com17 Jun 2020

This is because while the emergency authorisation for treating Covid was a recent move, the drug has been used since years for rheumatoid arthritis and autoimmune lupus.

Football Briefs: 'Arsenal responsible for Sanchez's missed drug test'

Football Briefs: 'Arsenal responsible for Sanchez's missed drug test'

Rediff.com26 Jan 2018

News of all that's transpired on and off the football field

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

Ranbaxy brands to stay alive

Ranbaxy brands to stay alive

Rediff.com8 Aug 2014

Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.

Now, Hospira under US FDA's lens

Now, Hospira under US FDA's lens

Rediff.com23 Dec 2013

Formal warning to Indian unit of deficiencies noted during inspection at facility near Chennai; firm says will remedy

Major rejig of portfolios after Fadnavis' cabinet expansion

Major rejig of portfolios after Fadnavis' cabinet expansion

Rediff.com10 Jul 2016

Maharashtra Chief Minister Devendra Fadnavis on Saturday allocated portfolios to newly sworn-in ministers and reshuffled certain portfolios.

Want to make Lakshadweep like Maldives, says collector

Want to make Lakshadweep like Maldives, says collector

Rediff.com27 May 2021

The Lakshadweep administration, which is under attack from the Opposition for its changes, on Thursday said it was laying the foundation for the future of islands in a planned way and to develop it on the lines of Maldives in two decades.

Johnson & Johnson pauses Covid vaccine trial as participant falls ill

Johnson & Johnson pauses Covid vaccine trial as participant falls ill

Rediff.com13 Oct 2020

The company has not yet revealed details about the unexplained illness but has stopped trials while doctors find out if the illness was caused due to the vaccine or was a coincidence.

Experts welcome WHO's decision to resume HCQ clinical trial

Experts welcome WHO's decision to resume HCQ clinical trial

Rediff.com4 Jun 2020

The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.

3rd minister quits Yogi cabinet, 10th MLA to leave BJP in UP

3rd minister quits Yogi cabinet, 10th MLA to leave BJP in UP

Rediff.com14 Jan 2022

OBC leader Dharam Singh Saini on Thursday became the third minister to resign from the Uttar Pradesh cabinet this week, giving yet another jolt to the ruling Bharatiya Janata Party in the run-up to the assembly polls.

Aaftab Poonawala to undergo narco test on December 1

Aaftab Poonawala to undergo narco test on December 1

Rediff.com29 Nov 2022

On Monday, Poonawala had come under an attack by some weapon-wielding men at the FSL when he was in a police van.

Sensex gains on Fed rally; posts best week since mid-June

Sensex gains on Fed rally; posts best week since mid-June

Rediff.com9 Oct 2015

Sensex, Nifty put up a good show in closing trade.

'Centre can't abdicate its responsibility'

'Centre can't abdicate its responsibility'

Rediff.com24 Apr 2023

'The Centre and state need to take a unified approach and take concerted action before this matter assumes menacing proportions because unemployment, the drug trade and the levels of frustration among the youth make them vulnerable to any maverick who promises something better.'

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

Rediff.com31 Dec 2013

The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.

Centre may not get costly Pfizer vaccine

Centre may not get costly Pfizer vaccine

Rediff.com22 Dec 2020

At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.

Ranbaxy sets aside Rs 257.4 cr for impact of USFDA ban

Ranbaxy sets aside Rs 257.4 cr for impact of USFDA ban

Rediff.com5 Feb 2014

Pharma major Ranbaxy Laboratories has set aside Rs 257.4 crore (Rs 2.57 billion) towards the financial impact of a US ban on import of products made at its plant at Toansa.

Govt panel recommends reducing Covid booster dose gap to 6 months

Govt panel recommends reducing Covid booster dose gap to 6 months

Rediff.com16 Jun 2022

The Standing Technical Sub-Committee (STSC) of the National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended reducing the gap between the second and precaution doses of COVID-19 vaccines from the current nine to six months, official sources said.

Indian drugmakers to pay higher facility fees on US hike

Indian drugmakers to pay higher facility fees on US hike

Rediff.com3 Aug 2014

The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products

US students who took Covaxin, Sputnik asked to get re-vaccinated

US students who took Covaxin, Sputnik asked to get re-vaccinated

Rediff.com4 Jun 2021

These vaccines have not yet been approved by the World Health Organization

Adverse effect of Covid-19 vaccine: What the law says

Adverse effect of Covid-19 vaccine: What the law says

Rediff.com15 Jan 2021

Laws governing compensation in case of adverse side effects for Covaxin and Covishield may differ in accordance with the kind of approvals given, say legal experts.